HIV Remission Studies & Starting ARVs Early

Step by Step At CROI 2017, HIV remission studies focus on early antiretroviral therapy initiation by Jeannie Wraight This year marked the 24th annual Conference on Retroviruses...

IV Drug Users & HIV Vaccine Response

Everyone Counts Differences in intravenous drug users may affect their response to an HIV vaccine by Jeannie Wraight Prevention strategies such as Treatment as Prevention, PrEP, syringe...

Cure Research Setback?

Shock and Kill Research unveils new info about latent HIV reservoirs, signaling a possible cure setback by Jeannie Wraight Amid several recent successes in the pursuit for...

Novel Cure Research Supported by amfAR

Deciphering the Puzzle A new round of amfAR's Countdown to a Cure initiative grants support novel cure research by Jeannie Wraight amfAR has awarded a new round...

The New Administration & the Threat to HIV Care and Cure...

Buyer Beware The new administration may threaten HIV care and cure research by Jeannie Wraight Our way of life in the U.S. has already drastically changed as...

ABX 464 Aims to Reduce HIV Reservoirs

Revving Up Investigational agent ABX 464 seeks to reduce HIV reservoirs by Jeannie Wraight ABX 464 is making its way through clinical trials, showing strong potential as...

LATEST POSTS

amfAR 2017 HIV Cure Summit

Although they announced no new breakthroughs in the search for an HIV cure, researchers at the University of California, San Francisco at amfAR’s 2017...

Cory Frederick: Advocate

A&U Honored by Healthline

Martin Wong: Gallery